Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant MYCN anticorps

L’anticorps anti-MYCN Monoclonal Lapin est utilisé pour la détection de MYCN dans des échantillons de Humain. Il a été validé pour WB.
N° du produit ABIN7828415
328,90 €
Plus frais de livraison 40,00 € et TVA
50 μL
Destination: France
Envoi sous 9 à 13 jours ouvrables

Aperçu rapide pour Recombinant MYCN anticorps (ABIN7828415)

Antigène

Voir toutes MYCN Anticorps
MYCN (N-Myc Proto-Oncogene Protein (MYCN))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 60
  • 43
  • 25
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 47
  • 18
Lapin

Clonalité

  • 48
  • 17
Monoclonal

Conjugué

  • 33
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MYCN est non-conjugé

Application

  • 25
  • 17
  • 13
  • 13
  • 7
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

A754
  • Fonction

    Recombinant N-Myc Monoclonal Antibody

    Purification

    Protein A purified

    Isotype

    IgG, kappa
  • Indications d'application

    WB 1:50000

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

    Date de péremption

    12 months
  • Antigène

    MYCN (N-Myc Proto-Oncogene Protein (MYCN))

    Autre désignation

    N-Myc

    Sujet

    BHLHe,MODED,N-myc,NMYC,ODED,bHLHe37,MYCN,Class E basic helix-loop-helix protein 37,N myc,N myc proto oncogene protein,Neuroblastoma derived v myc avian myelocytomatosis viral related oncogene,Neuroblastoma MYC oncogene,NMYC proto oncogene protein,N-myc proto-oncogene protein,Oncogene NMYC,pp65/67,V myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog,v myc avian myelocytomatosis viral related oncogene neuroblastoma derived,v myc myelocytomatosis viral related oncogene neuroblastoma derived,Members of the Myc/Max/Mad network function as transcriptional regulators with roles in various aspects of cell behavior, including proliferation, differentiation, and apoptosis. These proteins share a common basic-helix-loop-helix leucine zipper (bHLH-ZIP) motif required for dimerization and DNA-binding. Max was originally discovered based on its ability to associate with c-Myc and found to be required for the ability of Myc to bind DNA and activate transcription. Subsequently, Max has been viewed as a central component of the transcriptional network, forming homodimers as well as heterodimers with other members of the Myc and Mad families. The association between Max and either Myc or Mad can have opposing effects on transcriptional regulation and cell behavior. The Mad family consists of four related proteins, Mad1, Mad2 (Mxi1), Mad3, and Mad4, and the more distantly related members of the bHLH-ZIP family, Mnt and Mga. Like Myc, the Mad proteins are tightly regulated with short half-lives. In general, Mad family members interfere with Myc-mediated processes, such as proliferation, transformation, and prevention of apoptosis by inhibiting transcription.In humans the Myc family consists of 5 genes: c-Myc, N Myc, L-Myc, R-Myc, and B-Myc. While c-Myc is expressed in many proliferating cells, N-Myc expression is very restricted, with highest levels in during embryonic development and then in the adult during B-cell development. These expression patterns and results from targeted deletion of N-Myc suggest that N-Myc plays an important role in tissue development and differentiation. In addition, amplification or overexpression of N-Myc has been found in human neuroblastomas and is associated with rapid progression and poor prognosis. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [

    Poids moléculaire

    Calculated MW: 50 kDa

    Observed MW: 62 kDa The actual band is not consistent with the expectation.

    UniProt

    P04198
Vous êtes ici:
Chat with us!